Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 11/20 | 0.73 |
| ▸ | MAPT | P10636 | 8/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.73 |
| ▸ | LMNA | P02545 | 4/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.73 |
| ▸ | USP2 | O75604 | 4/20 | 0.73 |
| ▸ | TP53 | P04637 | 4/20 | 0.73 |
| ▸ | TSHR | P16473 | 3/20 | 0.73 |
| ▸ | MT-ND4 | P03905 | 3/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | GMNN | O75496 | 1/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sumatrol SCHEMBL29929407 | 1.00 | CYP3A4 (0.73) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL6408904 | 0.89 | CYP3A4 (0.73) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL13845713 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL29351552 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL29388856 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL42253 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL9815546 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL20152380 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL19019920 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E | |
| Rotenone SCHEMBL13926662 | 0.84 | CYP3A4 (1.00) | CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242030-A1 | COMPOSITIONS COMPRISING A NON-BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-07-31 | — | — | US | claimed |
| US-20250135072-A1 | COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-05-01 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023147048-A1 | COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| WO-2023147055-A1 | COMPOSITIONS COMPRISING A NON-BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2000062792-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING PESTS | INSECT BIOTECHNOLOGY, INC. (US) | 2000-10-26 | — | — | WO | claimed |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | NATURAL EXTRACTION SYS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | Natural Extraction Systems, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250242030-A1 | COMPOSITIONS COMPRISING A NON-BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250135072-A1 | COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-05-01 | — | — | US | disclosed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | disclosed |
| WO-2000062792-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING PESTS | INSECT BIOTECHNOLOGY, INC. (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-1999063818-A1 | USE OF AT LEAST ONE ACID FROM THE CITRIC ACID CYCLE COMBINED WITH GLYCERINE AS A PESTICIDE | BIOLINK TECHNOLOGIES AG (CH) | 1999-12-16 | — | — | WO | disclosed |
| US-5609878-A | ADSORBENT POLYMER | GUEYNE JEAN (MC) | 1997-03-11 | — | — | US | disclosed |
| EP-0588857-B1 | INSECTICIDE COMPOSITION | GUEYNE JEAN (MC) | 1997-01-15 | — | — | EP | disclosed |
| EP-0588857-A1 | INSECTICIDE COMPOSITION. | GUEYNE JEAN (MC) | 1994-03-30 | — | — | EP | disclosed |
| WO-1992021242-A1 | INSECTICIDE COMPOSITION | GUEYNE JEAN (MC) | 1992-12-10 | — | — | WO | disclosed |
| US-4690775-A | Emulsion-based gel and process for preparing same | RESEARCH CORPORATION (US) | 1987-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12409152-B2 | Compositions and methods related to dissolved oxides | PRKG2, PRKG1, CIT | CYP3A4 3252/4885MAPT 2118/4885SMN1; SMN2 3703/4885 |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | SCO2, CNR2, CNR1 | CYP3A4 1840/4885MAPT 3552/4885SMN1; SMN2 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.